• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nkarta, Inc. - Common Stock (NQ:NKTX)

3.470 +0.670 (+23.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,171,628
Open 2.830
Bid (Size) 3.450 (200)
Ask (Size) 3.470 (1,500)
Prev. Close 2.800
Today's Range 2.790 - 3.485
52wk Range 1.630 - 3.485
Shares Outstanding 48,934,928
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
April 15, 2026
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta to Participate in Needham Virtual Healthcare Conference
April 09, 2026
From Nkarta, Inc.
Via GlobeNewswire

Performance

YTD
+85.6%
+85.6%
1 Month
+59.9%
+59.9%
3 Month
+70.1%
+70.1%
6 Month
+42.2%
+42.2%
1 Year
+87.6%
+87.6%

More News

Read More
News headline image
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights
March 25, 2026
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta to Participate in March Investor Conferences
February 27, 2026
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta to Participate in Evercore Healthcare Conference
December 02, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights
November 10, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta to Participate in November Investor Conferences
October 30, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting
October 22, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
August 28, 2025
Via Benzinga
News headline image
Nkarta Posts Narrower Loss in Q2 ↗
August 13, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights
August 12, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
June 06, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space ↗
May 15, 2025
Via Benzinga
News headline image
This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗
May 15, 2025
Via Benzinga
News headline image
Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights
May 14, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Top movers in Thursday's session ↗
March 27, 2025
Via Chartmill
News headline image
Top stock movements in today's session. ↗
March 27, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
March 27, 2025
Via Benzinga
News headline image
Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday? ↗
March 27, 2025
Via Benzinga
News headline image
Which stocks are gapping on Thursday? ↗
March 27, 2025
Via Chartmill
News headline image
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
March 26, 2025
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
December 05, 2024
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights
November 07, 2024
From Nkarta, Inc.
Via GlobeNewswire
News headline image
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗
October 08, 2024
Via Benzinga
News headline image
Why Nkarta Stock Is Soaring Today ↗
August 14, 2024
Via The Motley Fool

Frequently Asked Questions

Is Nkarta, Inc. - Common Stock publicly traded?
Yes, Nkarta, Inc. - Common Stock is publicly traded.
What exchange does Nkarta, Inc. - Common Stock trade on?
Nkarta, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nkarta, Inc. - Common Stock?
The ticker symbol for Nkarta, Inc. - Common Stock is NKTX on the Nasdaq Stock Market
What is the current price of Nkarta, Inc. - Common Stock?
The current price of Nkarta, Inc. - Common Stock is 3.470
When was Nkarta, Inc. - Common Stock last traded?
The last trade of Nkarta, Inc. - Common Stock was at 04/17/26 04:00 PM ET
What is the market capitalization of Nkarta, Inc. - Common Stock?
The market capitalization of Nkarta, Inc. - Common Stock is 169.80M
How many shares of Nkarta, Inc. - Common Stock are outstanding?
Nkarta, Inc. - Common Stock has 170M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap